At a glance
- Originator AstraZeneca
- Class Antidepressants
- Mechanism of Action Serotonin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 07 Apr 1999 Merger of Astra and Zeneca to form AstraZeneca completed
- 14 Aug 1996 Discontinued-Clinical for Depression in Australia (PO)
- 14 Aug 1996 Discontinued-Clinical for Depression in Netherlands (PO)